Ovation Science Inc.
OVAT
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 47.40K | 48.50K | 45.50K | 46.30K | 65.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.40K | 48.50K | 45.50K | 46.30K | 65.20K |
| Cost of Revenue | 19.90K | 20.20K | 8.50K | 4.60K | 5.40K |
| Gross Profit | 27.50K | 28.30K | 37.00K | 41.70K | 59.80K |
| SG&A Expenses | 451.40K | 456.90K | 354.80K | 346.50K | 368.40K |
| Depreciation & Amortization | -- | -- | 0.00 | 400.00 | 1.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 471.40K | 477.20K | 364.30K | 352.70K | 377.50K |
| Operating Income | -424.00K | -428.70K | -318.70K | -306.40K | -312.40K |
| Income Before Tax | -443.00K | -451.10K | -297.40K | -330.60K | -289.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.44 | -0.45 | -0.30 | -0.33 | -0.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -443.00K | -451.10K | -297.40K | -330.60K | -289.50K |
| EBIT | -424.00K | -428.70K | -318.70K | -306.40K | -312.40K |
| EBITDA | -352.60K | -427.10K | -317.10K | -304.80K | -310.60K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 145.35M | 141.89M | 140.46M | 140.46M | 134.85M |
| Average Diluted Shares Outstanding | 145.35M | 141.89M | 140.46M | 140.46M | 134.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |